S

Seirei Hamamatsu General Hospital | General Clinical Research Center

Research site
(Unclaimed)
Location
2-12-12 Sumiyoshi, Naka-ku, Hamamatsu, Hamamatsu, Shizuoka, Japan
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 30
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

The purpose of the study is to evaluate the efficacy of bedaquiline (BDQ) compared with rifamycin when administered as part of a treatment regimen wi...

Enrolling
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Drug: Rifampicin
Drug: Ethambutol

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian

Researchers are looking for a better way to prevent an ischemic stroke which occurs when a blood clot travelled to the brain in people who within the...

Enrolling
High-risk Transient Ischemic Attack
Acute Non-cardioembolic Ischemic Stroke
Drug: Placebo
Drug: Asundexian (BAY2433334)

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...

Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo

The purpose of this study is to investigate the efficacy and safety of NPC-12Y gel compared with placebo for skin lesions associated with tuberous sc...

Active, not recruiting
Tuberous Sclerosis Complex
Drug: NPC-12Y placebo gel
Drug: NPC-12Y gel

The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic i...

Enrolling
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Drug: Nipocalimab
Drug: Placebo

The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...

Active, not recruiting
Rheumatoid Arthritis
Drug: Filgotinib
Drug: Placebo to match filgotinib

This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients wi...

Active, not recruiting
Membranoproliferative Glomerulonephritis (MPGN)
Membranoproliferative Glomerulonephritis
Other: Placebo
Drug: Pegcetacoplan

Trial conditions

Arthritis (3 trials)
Breast Cancer (3 trials)
Rheumatoid Arthritis (3 trials)
Cerebral Infarction (2 trials)
Communicable Diseases (2 trials)
Coronary Artery Disease (2 trials)
Human Influenza (2 trials)
Infections (2 trials)
Ischemia (2 trials)
Ischemic Stroke (2 trials)

And 33 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems